Tower Research Capital (TRC)’s Cavium, Inc. CAVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-257
| Closed | -$22K | – | 4632 |
|
|
2018
Q2 | $22K | Sell |
257
-2,033
| -89% | -$163K | ﹤0.01% | 2400 |
|
|
2018
Q1 | $181K | Buy |
+2,290
| New | +$200K | 0.02% | 929 |
|
|
2017
Q2 | – | Sell |
-136
| Closed | -$10K | – | 4015 |
|
|
2017
Q1 | $10K | Sell |
136
-3,641
| -96% | -$244K | ﹤0.01% | 1820 |
|
|
2016
Q4 | $235K | Buy |
+3,777
| New | +$218K | 0.03% | 577 |
|
|
2016
Q3 | – | Sell |
-2,540
| Closed | -$99K | – | 5246 |
|
|
2016
Q2 | $99K | Buy |
2,540
+109
| +4% | +$5.39K | 0.01% | 1111 |
|
|
2016
Q1 | $149K | Buy |
2,431
+1,785
| +276% | +$103K | 0.02% | 393 |
|
|
2015
Q4 | $42K | Buy |
+646
| New | +$43.6K | 0.01% | 670 |
|
|
2015
Q3 | – | Sell |
-1,615
| Closed | -$112K | – | 5594 |
|
|
2015
Q2 | $112K | Sell |
1,615
-308
| -16% | -$21.6K | 0.01% | 711 |
|
|
2015
Q1 | $136K | Buy |
+1,923
| New | +$125K | 0.02% | 656 |
|
|
2014
Q4 | – | Sell |
-460
| Closed | -$23K | – | 5495 |
|
|
2014
Q3 | $23K | Sell |
460
-281
| -38% | -$14.2K | ﹤0.01% | 2211 |
|
|
2014
Q2 | $37K | Buy |
741
+679
| +1,095% | +$31.2K | ﹤0.01% | 1461 |
|
|
2014
Q1 | $3K | Sell |
62
-1,088
| -95% | -$42.8K | ﹤0.01% | 3797 |
|
|
2013
Q4 | $40K | Sell |
1,150
-2,944
| -72% | -$110K | 0.01% | 1601 |
|
|
2013
Q3 | $169K | Buy |
4,094
+3,698
| +934% | +$139K | 0.02% | 871 |
|
|
2013
Q2 | $14K | Buy |
+396
| New | +$13.2K | ﹤0.01% | 2094 |
|
Tower Research Capital (TRC)'s CAVM Position: Q3 2018 in Review
Tower Research Capital (TRC) sold out of Cavium, Inc. (CAVM) in Q3 2018, closing a stake of 257 shares — an estimated $22K sold.
Tower Research Capital (TRC) first reported a position in CAVM in Q2 2013 and held it in 15 quarters. The position peaked at $235K in Q4 2016. 0 funds tracked by Wall St. Rank hold CAVM as of Q3 2018.
- Tower Research Capital (TRC) reported no remaining Cavium, Inc. position as of Q3 2018 after selling out during the quarter.
- Tower Research Capital (TRC) sold 257 Cavium, Inc. shares in Q3 2018, an estimated $22K.
- Tower Research Capital (TRC) first reported a position in Cavium, Inc. in Q2 2013 and held it in 15 quarters.
- Tower Research Capital (TRC)'s Cavium, Inc. position peaked at $235K in Q4 2016.
- 0 funds tracked by Wall St. Rank held Cavium, Inc. as of Q3 2018.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2018, filed 13 Nov 2018.